TT, L., LR, L., GH, G., S, G., X, Z., XF, Z., . . . TJ, Z. (2026). Proline, a privileged fragment in drug design: Advances and future perspectives. European journal of medicinal chemistry, 308, 118685. https://doi.org/10.1016/j.ejmech.2026.118685
Chicago Style (17th ed.) CitationTT, Li, et al. "Proline, a Privileged Fragment in Drug Design: Advances and Future Perspectives." European Journal of Medicinal Chemistry 308 (2026): 118685. https://doi.org/10.1016/j.ejmech.2026.118685.
MLA (9th ed.) CitationTT, Li, et al. "Proline, a Privileged Fragment in Drug Design: Advances and Future Perspectives." European Journal of Medicinal Chemistry, vol. 308, 2026, p. 118685, https://doi.org/10.1016/j.ejmech.2026.118685.
Warning: These citations may not always be 100% accurate.
